Crohn's disease treatment and efficacy prediction methods
OwnerIra Shafraninventor
Life of this patent
Estimating the term…
Abstract
A method for determining a potential efficacy of an administration of immunotherapy for treating Crohn's disease includes screening for a presence of Mycobacterium avium ss. paratuberculosis (MAP) in a serum of a patient. In another embodiment, Crohn's disease is treated by screening for a presence of MAP in a serum of a patient and avoiding a use of immunotherapy as a primary treatment if the patient screens serologically positive for MAP. Preferably, the patient is treated with a regimen of antibiotics to eradicate a presence of MAP. Then, if necessary, immunotherapy may be undertaken, preferably following a regimen of probiotics.
Claims15
A method for determining a potential efficacy of an administration of immunotherapy for treating Crohn's disease, the method comprising the step of screening for a presence of Mycobacterium avium ss. paratuberculosis (MAP) in a serum of a patient.
A method for treating Crohn's disease comprising the steps of:
- screening for a presence of Mycobacterium avium ss. paratuberculosis (MAP) in a serum of a patient;
- and
- avoiding a use of immunotherapy as a primary treatment if the patient screens serologically positive for MAP.
Dependencies are inferred from the claim text.